RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,061,800 | -15.6% | 1,196,409 | +26.1% | 3.05% | -24.7% |
| Q2 2023 | $11,915,157 | +15.7% | 948,659 | +51.7% | 4.05% | -5.8% |
| Q1 2023 | $10,301,738 | +45.0% | 625,485 | +31.5% | 4.30% | +52.2% |
| Q4 2022 | $7,103,746 | -33.2% | 475,485 | 0.0% | 2.83% | -17.8% |
| Q3 2022 | $10,637,000 | +33.6% | 475,485 | 0.0% | 3.44% | +27.9% |
| Q2 2022 | $7,964,000 | -44.0% | 475,485 | 0.0% | 2.69% | -33.9% |
| Q1 2022 | $14,231,000 | – | 475,485 | – | 4.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |